JP2013535425A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535425A5 JP2013535425A5 JP2013518755A JP2013518755A JP2013535425A5 JP 2013535425 A5 JP2013535425 A5 JP 2013535425A5 JP 2013518755 A JP2013518755 A JP 2013518755A JP 2013518755 A JP2013518755 A JP 2013518755A JP 2013535425 A5 JP2013535425 A5 JP 2013535425A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- hydrogen
- amide
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000001257 hydrogen Substances 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- 125000000217 alkyl group Chemical group 0.000 claims 11
- 150000002431 hydrogen Chemical class 0.000 claims 10
- 150000001408 amides Chemical class 0.000 claims 9
- 125000003710 aryl alkyl group Chemical group 0.000 claims 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- -1 cyano, formyl Chemical group 0.000 claims 4
- 150000002148 esters Chemical class 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical class NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 2
- 125000005127 aryl alkoxy alkyl group Chemical group 0.000 claims 2
- 125000005015 aryl alkynyl group Chemical group 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- QFDISQIDKZUABE-UHFFFAOYSA-N 1,1'-bipiperidine Chemical compound C1CCCCN1N1CCCCC1 QFDISQIDKZUABE-UHFFFAOYSA-N 0.000 claims 1
- JRZGPXSSNPTNMA-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=CC=C2C(N)CCCC2=C1 JRZGPXSSNPTNMA-UHFFFAOYSA-N 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical group SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims 1
- 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 claims 1
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 1
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 claims 1
- 208000029364 generalized anxiety disease Diseases 0.000 claims 1
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 1
- 230000005032 impulse control Effects 0.000 claims 1
- 208000028173 post-traumatic stress disease Diseases 0.000 claims 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 1
- 150000003573 thiols Chemical group 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016182294A JP6899638B2 (ja) | 2010-07-01 | 2016-09-16 | 心的外傷後ストレス障害を治療する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36068610P | 2010-07-01 | 2010-07-01 | |
| US61/360,686 | 2010-07-01 | ||
| PCT/US2011/042785 WO2012003436A1 (en) | 2010-07-01 | 2011-07-01 | Methods for treating post traumatic stress disorder |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016182294A Division JP6899638B2 (ja) | 2010-07-01 | 2016-09-16 | 心的外傷後ストレス障害を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535425A JP2013535425A (ja) | 2013-09-12 |
| JP2013535425A5 true JP2013535425A5 (https=) | 2014-07-31 |
Family
ID=45402462
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518755A Pending JP2013535425A (ja) | 2010-07-01 | 2011-07-01 | 心的外傷後ストレス障害を治療する方法 |
| JP2016182294A Active JP6899638B2 (ja) | 2010-07-01 | 2016-09-16 | 心的外傷後ストレス障害を治療する方法 |
| JP2019075883A Active JP7344532B2 (ja) | 2010-07-01 | 2019-04-11 | 心的外傷後ストレス障害を治療する方法 |
| JP2021113745A Pending JP2021169483A (ja) | 2010-07-01 | 2021-07-08 | 心的外傷後ストレス障害を治療する方法 |
| JP2023104161A Pending JP2023120400A (ja) | 2010-07-01 | 2023-06-26 | 心的外傷後ストレス障害を治療する方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016182294A Active JP6899638B2 (ja) | 2010-07-01 | 2016-09-16 | 心的外傷後ストレス障害を治療する方法 |
| JP2019075883A Active JP7344532B2 (ja) | 2010-07-01 | 2019-04-11 | 心的外傷後ストレス障害を治療する方法 |
| JP2021113745A Pending JP2021169483A (ja) | 2010-07-01 | 2021-07-08 | 心的外傷後ストレス障害を治療する方法 |
| JP2023104161A Pending JP2023120400A (ja) | 2010-07-01 | 2023-06-26 | 心的外傷後ストレス障害を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9376424B2 (https=) |
| EP (2) | EP3351104B1 (https=) |
| JP (5) | JP2013535425A (https=) |
| CN (2) | CN107007596A (https=) |
| AU (2) | AU2011272738B2 (https=) |
| CA (1) | CA2804001C (https=) |
| ES (2) | ES2858499T3 (https=) |
| PL (2) | PL3351104T3 (https=) |
| RU (1) | RU2623209C9 (https=) |
| WO (1) | WO2012003436A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3351104T3 (pl) * | 2010-07-01 | 2021-06-14 | Azevan Pharmaceuticals, Inc. | Związki do stosowania w leczeniu okresowych zaburzeń wybuchowych |
| SG10202001065SA (en) * | 2014-03-28 | 2020-04-29 | Azevan Pharmaceuticals Inc | Compositions and methods for treating neurodegenerative diseases |
| US10607634B1 (en) | 2017-03-13 | 2020-03-31 | Thomas G. Lavoie | Light monitoring circuit for a manual to automatic turntable conversion |
| MX2020002762A (es) * | 2017-09-15 | 2020-09-17 | Azevan Pharmaceuticals Inc | Composiciones y métodos para tratar una lesión cerebral. |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| US4314081A (en) | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| NL7503310A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| US4576753A (en) | 1975-10-06 | 1986-03-18 | Fujisawa Pharmaceutical Co., Ltd. | Azetidinone compounds and processes for preparation thereof |
| GB1526331A (en) | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| US4341698A (en) | 1979-06-21 | 1982-07-27 | Richardson-Merrell Inc. | Enkaphalin derivatives |
| US4536518A (en) | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| JPS6033439B2 (ja) | 1980-03-07 | 1985-08-02 | 財団法人相模中央化学研究所 | ジペプチドの製造方法 |
| JPS56125361A (en) | 1980-03-07 | 1981-10-01 | Sagami Chem Res Center | Azetidinone compound |
| FR2508035A1 (fr) | 1981-06-23 | 1982-12-24 | Fabre Sa Pierre | Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central |
| US4761501A (en) | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
| US4751299A (en) | 1983-11-18 | 1988-06-14 | Takeda Chemical Industries, Ltd. | Optically active β-lactams and method of their production |
| JPS6125361A (ja) | 1984-07-16 | 1986-02-04 | Canon Inc | 記録装置 |
| US4665171A (en) | 1985-07-17 | 1987-05-12 | Harvard University | Process and intermediates for β-lactam antibiotics |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4734498A (en) | 1986-07-10 | 1988-03-29 | Eli Lilly And Company | 3β-succinimidoazetidinones as chiral intermediates |
| US4772694A (en) | 1986-07-24 | 1988-09-20 | Eli Lilly And Company | Chiral 3-(1,2,5-trisubstituted imidazolidinone) azetidinone antibiotic intermediates |
| US4956388A (en) | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
| US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| US5627165A (en) | 1990-06-13 | 1997-05-06 | Drug Innovation & Design, Inc. | Phosphorous prodrugs and therapeutic delivery systems using same |
| AU687754B2 (en) | 1990-08-31 | 1998-03-05 | Warner-Lambert Company | Tachykinin antagonists |
| CA2093125C (en) | 1990-10-02 | 2003-12-16 | Warner-Lambert Company | Angiotensin ii antagonists |
| GB9204001D0 (en) | 1992-02-25 | 1992-04-08 | Jacobs Suchard Ag | Process for producing reduced fat nuts |
| US5246943A (en) | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
| WO1994001402A1 (en) | 1992-07-13 | 1994-01-20 | Merck Sharp & Dohme Limited | Heterocyclic amide derivatives as tachykinin derivatives |
| FR2696178B1 (fr) | 1992-09-30 | 1994-12-30 | Sanofi Elf | Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
| WO1994026735A1 (en) | 1993-05-06 | 1994-11-24 | Merrell Dow Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| US5516774A (en) * | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| US5512563A (en) | 1993-07-29 | 1996-04-30 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| US5759865A (en) | 1995-05-03 | 1998-06-02 | Eli Lilly And Company | Combinatorial process for synthesizing azetidinone analogs |
| GB9511694D0 (en) | 1995-06-09 | 1995-08-02 | Fujisawa Pharmaceutical Co | Benzamide derivatives |
| WO1997030707A1 (en) | 1996-02-23 | 1997-08-28 | Eli Lilly And Company | NON-PEPTIDYL VASOPRESSIN V1a ANTAGONISTS |
| AU5597098A (en) * | 1996-12-13 | 1998-07-03 | Eli Lilly And Company | Inhibitors of the enzymatic activity of psa |
| BR9811585A (pt) | 1997-07-30 | 2000-09-26 | American Home Prod | Agonistas de vasopressinas tricìclicas |
| US6403632B1 (en) | 2000-03-01 | 2002-06-11 | Bristol Myers Squibb Pharma Co | Lactam metalloprotease inhibitors |
| MXPA00004036A (es) | 1997-10-27 | 2006-05-24 | Reddys Lab Ltd Dr | Compuestos triciclicos novedosos y su uso en medicina; proceso para su preparacion y composiciones farmaceuticas que los contienen.. |
| ATE518540T1 (de) | 1999-08-16 | 2011-08-15 | Revaax Pharmaceuticals Llc | Beta-lactam verbindung enthaltende neurotherapeutische zusammensetzung |
| GB0019006D0 (en) | 2000-08-04 | 2000-09-20 | Astrazeneca Ab | Novel compounds |
| MXPA04003358A (es) | 2001-10-12 | 2004-07-08 | Serenix Pharmaceuticals Llc | Antagonistas de vasopresina v1a de ?-lactamilo. |
| WO2003051314A2 (en) | 2001-12-18 | 2003-06-26 | Medallion Biomedical, Llc | Antibiotic compounds |
| US7135479B2 (en) | 2002-09-12 | 2006-11-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| GB0224919D0 (en) | 2002-10-25 | 2002-12-04 | Pfizer Ltd | Triazole compounds useful in therapy |
| IS7839A (is) * | 2002-11-22 | 2004-05-23 | Merck Frosst Canada Ltd. | 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar |
| RS20060018A (sr) | 2003-07-14 | 2007-12-31 | Arena Pharmaceuticals Inc., | Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja |
| TW200526651A (en) | 2003-10-03 | 2005-08-16 | Serenix Pharmaceuticals Llc | 3-substituted β-lactamyl vasopressin V1a antagonists |
| US7745630B2 (en) | 2003-12-22 | 2010-06-29 | Justin Stephen Bryans | Triazolyl piperidine arginine vasopressin receptor modulators |
| EP1632494A1 (en) * | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
| EP1669776A1 (de) | 2004-12-11 | 2006-06-14 | Leica Geosystems AG | Handhaltbares Vermessungsgerät und Vermessungsverfahren für ein solches Vermessungsgerät |
| FR2881744B1 (fr) | 2005-02-09 | 2007-04-27 | Sanofi Aventis Sa | Derives de n-[(4,5-diphenyl-2-thienyl)methyl]amine, leur preparation et leur application en therapeutique |
| WO2006102283A2 (en) | 2005-03-22 | 2006-09-28 | Azevan Pharmaceuticals, Inc. | Beta-lactamylalkanoic acids for treating premenstrual disorders |
| CA2608718A1 (en) | 2005-05-18 | 2006-11-23 | Pfizer Limited | 1, 2, 4-triazole derivatives as vasopressin antagonists |
| EP1910346B1 (en) | 2005-07-19 | 2019-02-27 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonist |
| WO2007109615A2 (en) | 2006-03-21 | 2007-09-27 | Azevan Pharmaceuticals, Inc. | β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS |
| US20100016274A1 (en) | 2006-09-14 | 2010-01-21 | Koppel Gary A | Beta-lactam cannabinoid receptor modulators |
| JP2010504352A (ja) | 2006-09-22 | 2010-02-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | バソプレッシン拮抗薬としてのスピロベンズアゼピン類 |
| FR2927625B1 (fr) | 2008-02-19 | 2010-03-12 | Sanofi Aventis | Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique |
| FR2930249B1 (fr) | 2008-04-21 | 2010-05-14 | Sanofi Aventis | Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique. |
| PL3351104T3 (pl) * | 2010-07-01 | 2021-06-14 | Azevan Pharmaceuticals, Inc. | Związki do stosowania w leczeniu okresowych zaburzeń wybuchowych |
| CN105263910A (zh) | 2013-02-18 | 2016-01-20 | 斯克利普斯研究所 | 具有治疗潜力的血管加压素受体调节剂 |
| SG10202001065SA (en) | 2014-03-28 | 2020-04-29 | Azevan Pharmaceuticals Inc | Compositions and methods for treating neurodegenerative diseases |
| MX2020002762A (es) | 2017-09-15 | 2020-09-17 | Azevan Pharmaceuticals Inc | Composiciones y métodos para tratar una lesión cerebral. |
-
2011
- 2011-07-01 PL PL17200822T patent/PL3351104T3/pl unknown
- 2011-07-01 EP EP17200822.9A patent/EP3351104B1/en active Active
- 2011-07-01 CN CN201710230040.9A patent/CN107007596A/zh active Pending
- 2011-07-01 WO PCT/US2011/042785 patent/WO2012003436A1/en not_active Ceased
- 2011-07-01 PL PL11801485T patent/PL2587919T3/pl unknown
- 2011-07-01 CA CA2804001A patent/CA2804001C/en active Active
- 2011-07-01 JP JP2013518755A patent/JP2013535425A/ja active Pending
- 2011-07-01 AU AU2011272738A patent/AU2011272738B2/en active Active
- 2011-07-01 ES ES17200822T patent/ES2858499T3/es active Active
- 2011-07-01 EP EP11801485.1A patent/EP2587919B1/en active Active
- 2011-07-01 CN CN201180037339.3A patent/CN103269584B/zh active Active
- 2011-07-01 US US13/807,613 patent/US9376424B2/en active Active
- 2011-07-01 RU RU2012158025A patent/RU2623209C9/ru active
- 2011-07-01 ES ES11801485.1T patent/ES2662350T3/es active Active
-
2015
- 2015-11-18 AU AU2015258200A patent/AU2015258200B2/en active Active
-
2016
- 2016-04-21 US US15/134,549 patent/US9987265B2/en active Active
- 2016-09-16 JP JP2016182294A patent/JP6899638B2/ja active Active
-
2018
- 2018-05-23 US US15/987,053 patent/US10953001B2/en active Active
-
2019
- 2019-04-11 JP JP2019075883A patent/JP7344532B2/ja active Active
-
2021
- 2021-07-08 JP JP2021113745A patent/JP2021169483A/ja active Pending
-
2023
- 2023-06-26 JP JP2023104161A patent/JP2023120400A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009102535A (ru) | Производные карбамидов тропана, их получение и их применение в терапии | |
| JP2017538785A5 (https=) | ||
| RU2010138577A (ru) | ИНГИБИТОРЫ РЕЦЕПТОРА ХЕМОКИНА CxCR3 | |
| JP2010515750A5 (https=) | ||
| MX2009009492A (es) | Compuestos organicos biciclicos adecuados para el tratamiento de condiciones inflamatorias o alergicas. | |
| JP2013530176A5 (https=) | ||
| PH12012502572A1 (en) | Novel nicotinamide derivative or salt thereof | |
| RU2014122033A (ru) | Соединения с нематоцидной активностью | |
| JP2011529054A5 (https=) | ||
| JP2012515219A5 (https=) | ||
| JP2014051526A5 (https=) | ||
| JP2011513305A5 (https=) | ||
| MX2013010631A (es) | Derivados de n-(3-carbamoilfenil)-1h-pirazol-5-carboxamida y el uso de los mismos para el control de plagas de animales. | |
| RU2017123114A (ru) | 3-оксо-3-(ариламино)пропионаты, способ их получения и их применение в получении пирролидинонов | |
| JP2011515482A5 (https=) | ||
| JP2013535425A5 (https=) | ||
| JP2014520072A5 (https=) | ||
| JP2016506960A5 (https=) | ||
| RU2015100901A (ru) | Производные эфира гетероарилкарбоновой кислоты | |
| EA201001127A1 (ru) | Производные пиридина | |
| JP2020527175A5 (https=) | ||
| TW200628154A (en) | Organic compounds | |
| RU2014122035A (ru) | Соединения с нематоцидной активностью | |
| EA201391341A1 (ru) | Производные гетероциклических аминов | |
| JP2012504608A5 (https=) |